Page last updated: 2024-10-22

amobarbital and Myxedema

amobarbital has been researched along with Myxedema in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boruchow, IB1
Miller, LD1
Fitts, WT1

Other Studies

1 other study available for amobarbital and Myxedema

ArticleYear
Paralytic ileus in myxedema.
    Archives of surgery (Chicago, Ill. : 1960), 1966, Volume: 92, Issue:6

    Topics: Adult; Amobarbital; Barium; Dextroamphetamine; Female; Humans; Intestinal Neoplasms; Intestinal Obst

1966